UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.11 +0.11 (+0.14%) GOLD FUTURES
2,309.90 -1.10 (-0.05%) DOW
38,135.07 +231.78 (+0.61%) Bitcoin GBP
47,126.60 +1,763.26 (+3.89%)
Aileron Therapeutics, Inc. (ALRN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:13PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 70.78M |
| Enterprise value | 53.51M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 10.28 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.24 |
| 52-week change 3 | 207.01% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 7.4200 |
| 52-week low 3 | 1.0100 |
| 50-day moving average 3 | 5.3787 |
| 200-day moving average 3 | 3.1219 |
Share statistics
| Avg vol (3-month) 3 | 80.9k |
| Avg vol (10-day) 3 | 324.89k |
| Shares outstanding 5 | 16.97M |
| Implied shares outstanding 6 | 16.97M |
| Float 8 | 16.81M |
| % held by insiders 1 | 0.20% |
| % held by institutions 1 | 18.31% |
| Shares short (15 Apr 2024) 4 | 43.41k |
| Short ratio (15 Apr 2024) 4 | 1.17 |
| Short % of float (15 Apr 2024) 4 | 0.27% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.26% |
| Shares short (prior month 15 Mar 2024) 4 | 32.95k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 11 Nov 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -14.99% |
| Return on equity (ttm) | -26.91% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -15.23M |
| Net income avi to common (ttm) | -15.73M |
| Diluted EPS (ttm) | -3.4200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 17.31M |
| Total cash per share (mrq) | 1.02 |
| Total debt (mrq) | 48k |
| Total debt/equity (mrq) | 0.05% |
| Current ratio (mrq) | 4.17 |
| Book value per share (mrq) | 1.41 |
Cash flow statement
| Operating cash flow (ttm) | -19.81M |
| Levered free cash flow (ttm) | -7.62M |
© 2024 Yahoo. All rights reserved.